Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

TELA Bio Q1 2024 Adj EPS $(0.54) Misses $(0.50) Estimate, Sales $16.603M Beat $16.319M Estimate

Author: Benzinga Newsdesk | May 09, 2024 05:15pm
TELA Bio (NASDAQ:TELA) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate of $(0.50) by 8 percent. This is a 14.29 percent increase over losses of $(0.63) per share from the same period last year. The company reported quarterly sales of $16.603 million which beat the analyst consensus estimate of $16.319 million by 1.74 percent. This is a 39.42 percent increase over sales of $11.909 million the same period last year.

Posted In: TELA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist